http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-529448-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23c1033c984fbdf8d54fc38476b026b1 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate | 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f14c371d9d0d054c26362127a1e20e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c480893830e42475cde9bf98fb6a4b6a |
publicationDate | 2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-529448-A |
titleOfInvention | Castanospermine esters for treating flavivirus infections |
abstract | A castanospermine ester is described to be used in the manufacture of a medicament for the therapy or prophylaxis of a Flavivirdae infection. The medicament is disclosed to comprise a castanospermine ester of formula (I), wherein R, R1 and R2 are independently selected from the following substitutents: hydrogen; C1-14 alkanoyl; C2-14 alkenoyl; cyclohexanecarbonyl; C1-8 alkoxyacetyl; naphtha-lenecarbonyl optionally substituted by methyl or halogen; phenyl(C2-6 alkanoyl) wherein the phenyl is optionally substituted by methyl or halogen; cinnamoyl; pyridinecarbonyl optionally substituted by methyl or halogen; dihydropyridine carbonyl optionally substituted by methyl or halogen; dihydropyridine carbonyl optionally substituted by C1-10 alkyl; thiophenecarbonyl optionally substituted by methyl or halogen; furancarbonyl optionally substituted by methyl or halogen; or a compound of the formula (II) wherein Y is hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen, trifluoromethyl, C1-4 alkyl, C1-4 alkylsulphonyl, C1-4 alkylmercapto, cyano or dimethylamino; Y' is hydrogen, C1-4 alkyl, C1-4 alkoxy or halogen; wherein at least one, but not more that two, of R, R1 and R2 is hydrogen; or a pharmaceutically acceptable salt or derivative thereof. |
priorityDate | 2001-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 593.